In this thesis, I describe the development of a novel method to selectively modulate neural activity cell-type selectively. Binding of Zolpidem, an allosteric modulator that enhances GABAa receptor function and the inverse agonist β-carboline, require a phenylalanine residue (F77) in the γ subunit.